Naltrexone plus bupropion combination medication maintenance treatment for binge-eating disorder following successful acute treatments: randomized double-blind placebo-controlled trial.
Carlos M GriloJanet A LydeckerRalitza GueorguievaPublished in: Psychological medicine (2023)
Adult patients with BED with co-occurring obesity who have good responses to acute treatment with naltrexone/bupropion should be offered maintenance treatment with naltrexone/bupropion.
Keyphrases
- double blind
- placebo controlled
- liver failure
- clinical trial
- metabolic syndrome
- type diabetes
- insulin resistance
- healthcare
- weight loss
- randomized controlled trial
- open label
- adipose tissue
- emergency department
- respiratory failure
- phase iii
- study protocol
- physical activity
- drug induced
- hepatitis b virus
- aortic dissection
- alcohol use disorder